Health Early ACE Inhibitor Use for Scleroderma Renal Crisis Not Tied to Lower Mortality James Pereira Dec 5, 2022 Angiotensin-converting enzyme (ACE)… Read More...
Health Pre-Op Axitinib Helps for Partial Nephrectomy of Complex Renal Tumors James Pereira Dec 3, 2022 SAN DIEGO -- Use of neoadjuvant axitinib (Inlyta)… Read More...
Health Corvus Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Ciforadenant as… James Pereira Oct 26, 2022 BURLINGAME, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq:… Read More...
Health New HRS Drug Cuts Need for Renal Replacement Tx After Liver Transplant James Pereira Oct 26, 2022 Terlipressin (Terlivaz) reduced the need for… Read More...
Health U.S. Patent & Trademark Office Allows AVEO Oncology’s Patent Application Covering Use of… James Pereira Oct 13, 2022 BOSTON, Oct. 12, 2022 (GLOBE NEWSWIRE) -- AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused… Read More...
Health Metastatic Renal Cell Carcinoma Clinical Trials Pipeline Landscape Analysis of 45+ Companies by… James Pereira Oct 5, 2022 New York, USA, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Metastatic Renal Cell Carcinoma Clinical Trials Pipeline Landscape… Read More...
Health Three Adjuvant Immunotherapy Trials Flop in Renal Cell Carcinoma James Pereira Sep 13, 2022 PARIS -- While pembrolizumab (Keytruda) has been approved… Read More...
Health Is Remdesivir OK for COVID Patients With Severe Renal Impairment? James Pereira Aug 29, 2022 Antiviral remdesivir… Read More...
Health Global Renal Denervation (RDN) Market is valued at $140 Million (2022) and is growing at a lucrative… James Pereira Jun 6, 2022 Brussels, Belgium, June 06, 2022 (GLOBE NEWSWIRE) -- Description: Resistant hypertension is a blood pressure that… Read More...
Health Vera Therapeutics Announces New Atacicept Phase 2 Clinical Data in Two Oral Presentations at the… James Pereira May 21, 2022 Atacicept is the first known investigational therapy to decrease both circulatory Gd-IgA1 and anti-Gd-IgA1… Read More...